The $110 Billion Paramount-WBD Merger Is on a Collision Course With a March 2027 Trial

On August 4, 2026, U.S. District Judge Araceli Martínez-Olguín in Oakland, California, set a trial date of March 2, 2027 for two consolidated antitrust lawsuits seeking to block Paramount Skydance Corp.'s proposed $110 billion acquisition of Warner Bros. Discovery . The trial is scheduled to run for 12 days . The court will hear the case brought by a coalition of 12 state attorneys general alongside a separate suit filed by the Writers Guild of America .

This scheduling order from the federal judge in the Northern District of California lands midway between the two competing proposals: Paramount had pushed for a November trial, while California Attorney General Rob Bonta and the coalition of other state attorneys general requested an April 2027 start . The March date places the merger in a state of uncertainty for at least another seven months .

Financial Stakes: A Clock Ticking at $7 Million Per Day

The trial timing creates immense financial pressure on Paramount Skydance. Starting October 1, 2026, Paramount pays WBD shareholders approximately $7 million per day (a $0.25 per-share quarterly ticking amount) for every day the deal hasn't closed . With the trial set for March 2027 and a verdict likely weeks later, the ticking fee alone could exceed $1.18 billion by the time the deal could close .

Paramount lawyer Jeffrey Kessler told the judge the company "would suffer very severe harm" from the accumulating ticking fee . If the deal is delayed six months, Paramount would owe WBD shareholders $1.3 billion .

But the ticking fee is only half the story. If the deal is not complete by June 4, 2027, WBD CEO David Zaslav can contractually call off the merger and collect a $7 billion regulatory termination fee from Paramount . Because Paramount has agreed not to close the deal until June 2027 (or five days after trial ends), the litigation schedule leaves virtually no margin for error .

Core Antitrust Concerns: Two Lawsuits, One Trial

12-State Coalition — Led by California Attorney General Rob Bonta, the states of Arizona, Colorado, Connecticut, Massachusetts, Minnesota, Nevada, New Jersey, New Mexico, New York, Oregon, and Washington sued in mid-July 2026. They argue the merger would:

• Reduce competition for basic cable TV channel distribution
• Harm movie theaters and consumers through concentrated market power
• Lessen competition in the streaming and film industry

Writers Guild of America (WGA) — The WGA East and West jointly filed a separate antitrust suit on July 14, 2026, arguing the merger would:

• Violate federal antitrust law by consolidating two of Hollywood's largest studios
• Suppress writers' wages by reducing the number of competing buyers for creative labor
• Severely limit the greenlighting of original creative projects

The WGA's complaint quantifies the market concentration: Paramount and Warner Bros. Discovery together accounted for 35% of film writing jobs between 2021 and 2024, 36% of television writing projects from 2022 to 2025, and 38% of all writer deals across the industry .

Regulatory Approval Status

The U.S. Department of Justice Antitrust Division closed its investigation and cleared the deal on June 12, 2026, after an eight-month review that examined more than two million documents . The DOJ concluded the transaction "is not likely to result in harm to competition or American consumers" and imposed no divestiture conditions, behavioral remedies, or concessions . The clearance was unconditional .

The status of approval from the U.K. Competition and Markets Authority (CMA) is not clearly reported in available sources. The Wikipedia entry notes the transaction "awaits confirmation from regulating agencies" without specifying the CMA outcome . This represents an open evidence gap.

Why the Date Matters

The March 2027 trial date creates a high-stakes collision between the litigation calendar and the deal's financial deadlines. With the $7 million daily ticking fee starting October 2026 and the hard June 4, 2027 drop-dead date for the $7 billion termination fee, Paramount has a roughly three-month window between the expected trial verdict (likely late March to April 2027) and the termination deadline to close the transaction.

Any delay in the trial, a lengthy post-trial ruling, or an appeal could make the deal financially untenable or cause it to collapse entirely. The extended timing could trigger about $1.18 billion in ticking fees owed to shareholders, while failure to close the deal would add the full $7 billion termination payment .